These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1254 related items for PubMed ID: 28532651

  • 21. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE, Hellkamp AS, Yuan Z, Lokhnygina Y, Patel MR, Piccini JP, Hankey GJ, Breithardt G, Halperin JL, Becker RC, Hacke W, Nessel CC, Mahaffey KW, Fox KA, Califf RM, ROCKET AF Investigators.
    J Am Heart Assoc; 2015 Mar 03; 4(3):e001349. PubMed ID: 25736441
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region　- Analysis Using the National Health Insurance Database.
    Narita N, Okumura K, Kinjo T, Mikami J, Tsushima K, Takahashi R, Noro M, Hashimoto A, Sasaki T, Takaki M, Ishidoya E, Narita Y, Imai H, Ono E, Tomita H.
    Circ J; 2020 Apr 24; 84(5):706-713. PubMed ID: 32213724
    [Abstract] [Full Text] [Related]

  • 25. [Prothrombin time on admission in patients with cardioembolic stroke and intracranial hemorrhage occurring during warfarin treatment in the direct oral anticoagulant era].
    Okumura K, Hagii J, Metoki N, Saito S, Shiroto H, Yasujima M, Tomita H.
    Rinsho Shinkeigaku; 2016 May 31; 56(5):309-17. PubMed ID: 27151227
    [Abstract] [Full Text] [Related]

  • 26. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z, Burgess JF, Ozonoff A, Zhao S, Berlowitz D, Rose AJ.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 31; 8(6):600-7. PubMed ID: 26420820
    [Abstract] [Full Text] [Related]

  • 27. New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF.
    Goto S, Goto S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Haas S, Parkhomenko A, Oto A, Misselwitz F, Turpie AGG, Verheugt FWA, Fox KAA, Gersh BJ, Kakkar AK.
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep 01; 6(5):301-309. PubMed ID: 31821482
    [Abstract] [Full Text] [Related]

  • 28. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I, Tanahashi N, Takao M.
    J Stroke Cerebrovasc Dis; 2018 Oct 01; 27(10):2627-2631. PubMed ID: 29970321
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK, Lee MJ, Kim JH, Lee JS, Park RW, Kim GM, Chung CS, Lee KH, Kim JS, Lee SY, Bang OY.
    J Stroke Cerebrovasc Dis; 2017 Jun 01; 26(6):1383-1390. PubMed ID: 28412319
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
    Stacy ZA, Richter SK.
    Ther Adv Cardiovasc Dis; 2018 Sep 01; 12(9):247-262. PubMed ID: 30081727
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 63.